GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
57.40
+0.06 (0.10%)
May 8, 2025, 2:27 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
GeneDx
302.29M
Log In
Log In
Log In
GeneDx Growth
55.52%
Log In
Log In
Log In
Other
3.16M
Log In
Log In
Log In
Other Growth
-61.45%
Log In
Log In
Log In
Patients with Third-party Insurance
-
Log In
Log In
Log In
Institutional Customers
-
Log In
Log In
Log In
Self-pay Patients
-
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
United States
305.45M
Log In
Log In
Log In
United States Growth
50.79%
Log In
Log In
Log In